Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group

Kewaunee Scientific (NASDAQ: KEQU) appointed Jorge Santos as Vice President, International Sales, Laboratory Products Group, effective April 14, 2026.

Rhea-AI Summary

Kewaunee Scientific (NASDAQ: KEQU) appointed Jorge Santos as Vice President, International Sales, Laboratory Products Group, effective April 14, 2026. Santos, based in Madrid, brings over 20 years of international commercial leadership across 25+ countries to support global expansion following the NuAire acquisition. The move targets deeper penetration in Europe, Middle East, Asia, and continued strength in India under existing leadership.

The company said Santos will report to CEO Thomas D. Hull III and work alongside regional leaders to leverage Kewaunee and NuAire portfolios for integrated laboratory solutions worldwide.

Positive

• Experienced hire: Jorge Santos brings 20+ years of international commercial leadership
• Global reach: Santos has built dealer networks across 25+ countries, aiding expansion
• Acquisition synergy: Role intended to accelerate integration of Kewaunee and NuAire product portfolios

Negative

• Execution risk: Realizing benefits depends on successfully integrating NuAire into global operations
• Market concentration: India remains largest international market, creating geographic dependence risks
• International challenges: Expansion faces supply, regulatory, and currency risks noted in forward-looking statements

Argus Apr 15 session

+1.05% close to close Open Argus

Details

News Market Reaction – KEQU

In the Apr 15 session, KEQU gained 1.05%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Kewaunee’s push to deepen international sales capabilities, particularl...

Analysis

This announcement highlights Kewaunee’s push to deepen international sales capabilities, particularly following the Nu Aire acquisition and prior growth in markets such as India, Europe, and Asia. The hire adds experience across more than 25 countries and complements existing regional leadership. Investors may watch future disclosures for changes in international sales mix, backlog by region, and integration progress, as well as how global demand for advanced laboratory environments supports the company’s long-term expansion narrative.

Key Figures

Year founded: 1906 Nu Aire founding year: 1971 Countries covered: more than 25 countries +5 more

Year founded

1906

Kewaunee Scientific founding year

Nu Aire founding year

1971

Nu Aire, Inc. founding year

Countries covered

more than 25 countries

Scope of Jorge Santos’ dealer networks

Statesville plants

3 manufacturing facilities

Facilities in Statesville serving domestic and international markets

Bangalore plant

1 manufacturing facility

Facility in Bangalore serving local, Asian, and African markets

Planned growth horizon

next decade

Indian infrastructure investments referenced as growth backdrop

Headquarters location

Statesville, North Carolina

Corporate headquarters of Kewaunee Scientific

Nu Aire warehouse hub

Netherlands warehouse partnership

Logistics footprint mentioned for Nu Aire

Historical Context

5 past events · Latest: Mar 11

5 events

1. Mar 11

   Earnings release

   24h Move

   -13.1%

   Q3 2026 results showed higher sales but weaker net earnings and EPS.

2. Mar 03

   Conference presence

   24h Move

   -1.3%

   Announcement of attendance at analytica 2026 with integrated lab solutions.

3. Feb 25

   Earnings date notice

   24h Move

   -2.1%

   Scheduling update for Q3 2026 results release after market close.

4. Jan 15

   Order win

   24h Move

   +6.3%

   Unusual Machines announced a $2.1M NDAA-compliant drone component order.

5. Dec 10

   Earnings release

   24h Move

   -4.3%

   Q2 2026 results with strong revenue growth but lower pre-tax earnings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

biological safety cabinets, co2 incubators, forward-looking statements

3 terms

biological safety cabinets medical

"NuAire, Inc. (NuAire), is a leading manufacturer of biological safety cabinets, CO2 incubators..."

An enclosed, ventilated workspace that keeps lab workers, the surrounding environment, and delicate biological samples separate by controlling airflow and filtering out contaminants—think of it as a clean, protective box that prevents germs and particles from spreading. Investors care because these cabinets are required for safe research, clinical testing and manufacturing; their presence affects a lab’s ability to operate legally and reliably, influencing regulatory risk, operating costs and the pace at which scientific work can be commercialized.

co2 incubators medical

"NuAire, Inc. (NuAire), is a leading manufacturer of biological safety cabinets, CO2 incubators..."

A CO2 incubator is a laboratory device that creates and maintains a stable, warm, humid environment with controlled carbon dioxide levels so living cells and tissues can be grown and studied, similar to a small, climate-controlled greenhouse for cells. Investors care because these machines are essential tools for biotech, pharmaceutical and medical-research work, creating steady demand, consumable sales and replacement cycles that can indicate strength or growth in the life-sciences equipment market.

forward-looking statements regulatory

"This press release contains statements that the Company believes to be "forward-looking statements"..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STATESVILLE, N.C., April 14, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced the appointment of Jorge Santos as VP – International Sales – Lab Products Group, further strengthening the Company's commercial leadership as it accelerates growth in key global markets. Santos joins Kewaunee as the newest member of the Company's leadership team and will report directly to President and Chief Executive Officer, Thomas D. Hull III.

"Jorge's appointment marks a significant step forward in Kewaunee's growth strategy outside of the North American market," said Thomas D. Hull III, President & Chief Executive Officer of Kewaunee Scientific Corporation. "Historically, Kewaunee's focus outside of the North American market has been primarily within the Indian, Middle East, and Asia Pacific markets, with the Indian market being our largest, most successful market outside of the United States. With the addition of Nu Aire's diverse product portfolio and world class distribution partners into the Kewaunee family, new opportunities for global expansion exist and we are well positioned to take the next step in realizing these opportunities."

"Jorge is an industry veteran based in Madrid, Spain, with a proven track record of delivering high quality laboratory projects worldwide. Jorge joins Kewaunee with over two decades of international commercial and operational leadership, having guided market expansions, built several multi‑national sales organizations, and developed high‑performing dealer networks across more than 25 countries. His experience spans Europe, the Middle East, Latin America, and Asia, making him uniquely positioned to support and further advance Kewaunee's next phase of global growth. His leadership will help accelerate our momentum as we look to capitalize on the capabilities that the combined Kewaunee and Nu Aire portfolio bring to our global customers."

"Kewaunee is uniquely equipped to bring a more complete, integrated laboratory solution to the global market," Hull added. "With Jorge's experience and established relationships across Europe, the Middle East, and Asia, our path forward will be forged by strong leadership across our global organization and a clear vision for international expansion."

As Kewaunee's presence expands globally, the Company remains firmly committed to the leadership and focus that have long driven success in its core markets. Domestic sales operations for both Kewaunee and Nu Aire will continue under the leadership of Ryan Noble, Vice President of Sales & Market Development, whose driven and customer-focused approach has been instrumental in maintaining consistent execution, strong engagement, and healthy growth across the Company's key markets. Noble's deep regional expertise and close relationships with Kewaunee's customers and partners remain central to the Company's commercial success.

As the Indian economy continues to represent a robust, long term growth opportunity for the Company, B. Sathyamurthy (Sathya), President of Kewaunee International Group, will continue driving Kewaunee International Group operations. Sathya has spent more than 25 years building and scaling Kewaunee's International Group, helping establish India as an essential market within the Company's global operations. "Sathya and his team have developed a market‑leading turnkey capability that has resulted in a solution‑focused organization capable of serving customers across multiple end markets that require specialized engineering and furnishing expertise," Hull added. "These turnkey capabilities have set the team apart from the competition and created opportunities to expand the customer base served within India, capitalizing on a rapidly growing economy with significant infrastructure investments planned over the next decade."

Hull further emphasized that the Company's global expansion will continue to be built on strong, market-tailored leadership and focused investment. "We see an exciting opportunity ahead for Kewaunee on the global stage. I believe we have the strongest commercial leadership in the industry, and the addition of Jorge's experience and leadership further strengthens our organization and will help us deepen our presence in the markets where the demand for advanced laboratory environments continues to accelerate."

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville, serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India, serving the local, Asian, and African markets.

Kewaunee Scientific's newly acquired subsidiary, Nu Aire, Inc. (NuAire), is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, NuAire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.

Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/.

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the NuAire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:	Donald T. Gardner III
	704/871-3274

View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-corporation-appoints-jorge-santos-as-vice-president-of-international-sales-laboratory-products-group-302742110.html

SOURCE Kewaunee Scientific Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is Jorge Santos and what role did Kewaunee (KEQU) announce on April 14, 2026?

He is the new Vice President of International Sales for the Laboratory Products Group, based in Madrid. According to the company, Santos will report to CEO Thomas D. Hull III and lead global commercial expansion efforts leveraging Kewaunee and NuAire.

How does Jorge Santos' experience support Kewaunee (KEQU) international growth plans?

He has over 20 years of commercial and operational leadership across more than 25 countries. According to the company, that experience includes building multinational sales organizations and dealer networks across Europe, Middle East, Latin America, and Asia.

What markets will Jorge Santos focus on for Kewaunee (KEQU) after his appointment?

Primary focus areas include Europe, the Middle East, and Asia while maintaining strong engagement in India. According to the company, his relationships across these regions aim to deepen presence and sell integrated Kewaunee and NuAire solutions.

Does the appointment of Jorge Santos change Kewaunee's leadership in India (KEQU)?

No; B. Sathyamurthy will continue leading Kewaunee International Group operations in India. According to the company, Sathya remains responsible for the Indian market, which is the largest international market for Kewaunee.

What risks did Kewaunee (KEQU) identify related to its international expansion and the NuAire acquisition?

The company highlighted execution, supply chain, regulatory, and currency risks tied to international operations and integration. According to the company, realizing acquisition benefits depends on overcoming these operational and market challenges.